clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
New Genetic Variants May Help Explain Why More Boys Get Autism
News & Features
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Informatics
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities
News & Features
Study Suggests Cytomegalovirus Could Contribute to Alzheimer’s Pathology in Certain Individuals
News & Features
Mutated Cilia Implicated in Pathology of ALS
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Microbiome Evaluation Technique Helps Unlock Drug Efficacy and Safety
Clinical drug development
News & Features
Microbiome Evaluation Technique Helps Unlock Drug Efficacy and Safety
June 11, 2020
0
Coronavirus
Combination of Genentech’s Actemra, Gilead’s Remdesivir Enters Phase III Trial for Treatment of Severe COVID-19
May 28, 2020
0
Coronavirus
Moderna’s Phase I COVID-19 Trial Posts Positive Interim Data
May 19, 2020
0
Coronavirus
Moderna Gets FDA Green Light for COVID-19 Vaccine Phase II Trial
May 8, 2020
0
Coronavirus
Phase III COVID-19 Trial of Sanofi and Regeneron Drug Kevzara Narrowed to Critical Patients
April 29, 2020
0
Molecular Dx
Inivata, EORTC Partner to Study Liquid Biopsy in Assessing Resistance to Pfizer’s Lorbrena
October 29, 2019
0
News & Features
NIA Invests $73 Million in New Alzheimer’s Research Centers
October 2, 2019
0
News & Features
Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor
June 3, 2019
0
Molecular Dx
Merck Using PGDx Pan-Cancer Tissue Assay in Combination Therapy Trial
January 3, 2019
0
News & Features
AstraZeneca, Cancer Research UK Partner on Functional Genomics Center
December 10, 2018
0
1
...
17
18
19
Page 18 of 19
Related Content
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities
Genetic Importance for Flu Vaccine Protection Could Broaden Pandemic Preparedness
Brain Tumors Hijack Circadian Rhythms to Accelerate Growth
Microrobots Travel Deep Inside Body to Deliver Targeted Treatment
Inside Precision Medicine
![A three-protein biomarker panel has been established that is able to screen urine samples for signs of early-stage pancreatic cancer. [iStock/© David Marchal]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/289.jpeg "Pancreatic Cancer Patients with BRCA1/BRCA2 Respond to PARP Inhibitor")
